Is Macrobid (nitrofurantoin) safe to use in an elderly patient with impaired renal function, specifically a glomerular filtration rate (GFR) of 48?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nitrofurantoin Use in Elderly Patients with Reduced Renal Function

Nitrofurantoin (Macrobid) should not be used in elderly patients with a GFR of 48 mL/min due to reduced efficacy and increased risk of adverse effects.

Renal Function Considerations

  • Nitrofurantoin has traditionally been contraindicated in patients with creatinine clearance (CrCl) below 60 mL/min due to concerns about decreased urinary concentration and potential toxicity 1
  • A GFR of 48 mL/min falls into Stage 3 Chronic Kidney Disease (moderate decrease in GFR: 30-59 mL/min/1.73m²) 2
  • Reduced renal function can lead to:
    • Decreased urinary concentration of nitrofurantoin, potentially reducing efficacy 1
    • Increased serum levels of the drug, raising the risk of adverse effects 3

Efficacy Concerns

  • Nitrofurantoin's antimicrobial activity depends on achieving adequate urinary concentrations, which may be compromised in patients with reduced renal function 1
  • While some research suggests nitrofurantoin may still be effective in patients with CrCl between 30-60 mL/min, these studies have significant limitations 3
  • Treatment failure rates are higher in patients with reduced renal function compared to those with normal renal function 4

Safety Concerns

  • Elderly patients are already at higher risk for adverse drug reactions due to age-related physiological changes and polypharmacy 2
  • Nitrofurantoin can cause serious adverse effects including:
    • Pulmonary toxicity
    • Hepatotoxicity
    • Peripheral neuropathy
    • Hypersensitivity reactions 3
  • These risks may be amplified in patients with renal impairment 1

Alternative Options

  • Consider alternative antibiotics with better safety profiles in renal impairment:
    • Fluoroquinolones (with appropriate dose adjustments) 3
    • Trimethoprim-sulfamethoxazole (with dose adjustment) 3
    • Cephalosporins (with appropriate selection and dosing) 3
  • When selecting alternatives, consider:
    • Local resistance patterns
    • Patient's medication history
    • Risk of Clostridioides difficile infection
    • Drug interactions with other medications 2

Special Considerations for Elderly Patients

  • Elderly patients often have multiple comorbidities and take multiple medications, increasing the risk of drug interactions 2
  • Accurate assessment of renal function is critical, as serum creatinine alone may underestimate renal insufficiency in elderly patients due to decreased muscle mass 2
  • The Cockcroft-Gault equation or other age-appropriate GFR estimation methods should be used 5

Conclusion

While some recent studies have questioned the absolute contraindication of nitrofurantoin at GFR levels between 30-60 mL/min 4, 3, the preponderance of evidence and the potential for serious adverse effects in elderly patients with reduced renal function make nitrofurantoin a poor choice for an elderly patient with a GFR of 48 mL/min. Alternative antibiotics with established safety profiles in renal impairment should be selected instead.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nitrofurantoin safety and effectiveness in treating acute uncomplicated cystitis (AUC) in hospitalized adults with renal insufficiency: antibiotic stewardship implications.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017

Research

Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.